BDBM350662 US10208071, Compound 124::US10799518, Compound 124::{[(2S)-4-methyl-2-({[4- (trifluoromethyl)phenyl]carbamoyl} amino)pentanoyl]amino}acetic acid

SMILES CC(C)C[C@H](NC(=O)Nc1ccc(cc1)C(F)(F)F)C(=O)NCC(O)=O

InChI Key InChIKey=WGOPETHLVCCHMW-UHFFFAOYSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 350662   

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350662({[(2S)-4-methyl-2-({[4- (trifluoromethyl)phenyl]ca...)
Affinity DataEC50:  1.80nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350662({[(2S)-4-methyl-2-({[4- (trifluoromethyl)phenyl]ca...)
Affinity DataEC50:  1.80E+3nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent